{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:54:36Z","timestamp":1792166076215,"version":"4.4.0"},"reference-count":349,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence","award":["PI21\/01724"],"award-info":[{"award-number":["PI21\/01724"]}]},{"name":"Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence","award":["15826\/004"],"award-info":[{"award-number":["15826\/004"]}]},{"name":"Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence","award":["41163\/005"],"award-info":[{"award-number":["41163\/005"]}]},{"name":"Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence","award":["PMP21\/00015"],"award-info":[{"award-number":["PMP21\/00015"]}]},{"name":"Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence","award":["STARTUP2020\/L2566"],"award-info":[{"award-number":["STARTUP2020\/L2566"]}]},{"name":"European Union (FEDER)","award":["PI21\/01724"],"award-info":[{"award-number":["PI21\/01724"]}]},{"name":"European Union (FEDER)","award":["15826\/004"],"award-info":[{"award-number":["15826\/004"]}]},{"name":"European Union (FEDER)","award":["41163\/005"],"award-info":[{"award-number":["41163\/005"]}]},{"name":"European Union (FEDER)","award":["PMP21\/00015"],"award-info":[{"award-number":["PMP21\/00015"]}]},{"name":"European Union (FEDER)","award":["STARTUP2020\/L2566"],"award-info":[{"award-number":["STARTUP2020\/L2566"]}]},{"name":"Recovery and Resilience Mechanism","award":["PI21\/01724"],"award-info":[{"award-number":["PI21\/01724"]}]},{"name":"Recovery and Resilience Mechanism","award":["15826\/004"],"award-info":[{"award-number":["15826\/004"]}]},{"name":"Recovery and Resilience Mechanism","award":["41163\/005"],"award-info":[{"award-number":["41163\/005"]}]},{"name":"Recovery and Resilience Mechanism","award":["PMP21\/00015"],"award-info":[{"award-number":["PMP21\/00015"]}]},{"name":"Recovery and Resilience Mechanism","award":["STARTUP2020\/L2566"],"award-info":[{"award-number":["STARTUP2020\/L2566"]}]},{"name":"Madrid Autonomous Community","award":["PI21\/01724"],"award-info":[{"award-number":["PI21\/01724"]}]},{"name":"Madrid Autonomous Community","award":["15826\/004"],"award-info":[{"award-number":["15826\/004"]}]},{"name":"Madrid Autonomous Community","award":["41163\/005"],"award-info":[{"award-number":["41163\/005"]}]},{"name":"Madrid Autonomous Community","award":["PMP21\/00015"],"award-info":[{"award-number":["PMP21\/00015"]}]},{"name":"Madrid Autonomous Community","award":["STARTUP2020\/L2566"],"award-info":[{"award-number":["STARTUP2020\/L2566"]}]},{"name":"Fundaci\u00f3n Conchita R\u00e1bago (FCR, IIS-FJD) predoctoral scholarship","award":["PI21\/01724"],"award-info":[{"award-number":["PI21\/01724"]}]},{"name":"Fundaci\u00f3n Conchita R\u00e1bago (FCR, IIS-FJD) predoctoral scholarship","award":["15826\/004"],"award-info":[{"award-number":["15826\/004"]}]},{"name":"Fundaci\u00f3n Conchita R\u00e1bago (FCR, IIS-FJD) predoctoral scholarship","award":["41163\/005"],"award-info":[{"award-number":["41163\/005"]}]},{"name":"Fundaci\u00f3n Conchita R\u00e1bago (FCR, IIS-FJD) predoctoral scholarship","award":["PMP21\/00015"],"award-info":[{"award-number":["PMP21\/00015"]}]},{"name":"Fundaci\u00f3n Conchita R\u00e1bago (FCR, IIS-FJD) predoctoral scholarship","award":["STARTUP2020\/L2566"],"award-info":[{"award-number":["STARTUP2020\/L2566"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Anaplastic Large Cell Lymphoma (ALCL) represents a diverse group of mature T-Cell Lymphomas unified by strong CD30 expression but with different molecular and clinical subtypes. This review summarizes recent molecular advances in ALCL, highlighting key discoveries that have refined its classification, diagnosis, and therapeutic strategies. ALCL comprises four major entities: systemic ALK-positive ALCL, systemic ALK-negative ALCL, Breast Implant-Associated ALCL (BIA-ALCL), and primary cutaneous ALCL. Each subtype exhibits unique phenotypes, along with cytogenetic and molecular alterations that affect clinical outcomes. Nevertheless, different oncogenic mechanisms mediate STAT3 activation. In ALK-positive ALCL, ALK fusion proteins drive oncogenesis via constitutive activation of STAT3 and other signaling pathways. ALK-negative ALCL comprises heterogeneous genetic subtypes, in which JAK\/STAT3 pathway alterations and novel gene fusions are gaining recognition as potential therapeutic targets. This review emphasizes the need for integrative molecular diagnostics to improve stratification of ALCL subtypes and targeted treatment approaches. Future research should focus on elucidating the biological mechanisms underlying these alterations and on translating molecular insights into clinical practice.<\/jats:p>","DOI":"10.3390\/ijms26125871","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T06:11:07Z","timestamp":1750313467000},"page":"5871","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Molecular Insights into the Diagnosis of Anaplastic Large Cell Lymphoma: Beyond Morphology and Immunophenotype"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8673-3165","authenticated-orcid":false,"given":"Jes\u00fas","family":"Frutos D\u00edaz-Alejo","sequence":"first","affiliation":[{"name":"Pathology Department, Instituto de Investigaci\u00f3n Sanitaria-Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9054-4359","authenticated-orcid":false,"given":"Iv\u00e1n","family":"Prieto-Pot\u00edn","sequence":"additional","affiliation":[{"name":"Pathology Department, Instituto de Investigaci\u00f3n Sanitaria-Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5450-4146","authenticated-orcid":false,"given":"Rebeca","family":"Manso","sequence":"additional","affiliation":[{"name":"Pathology Department, Instituto de Investigaci\u00f3n Sanitaria-Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8543-6767","authenticated-orcid":false,"given":"Marta","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Pathology Department, Instituto de Investigaci\u00f3n Sanitaria-Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1242-6669","authenticated-orcid":false,"given":"Marcos","family":"Rebollo-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Pathology Department, Instituto de Investigaci\u00f3n Sanitaria-Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7070-0550","authenticated-orcid":false,"given":"Francisco Javier","family":"D\u00edaz de la Pinta","sequence":"additional","affiliation":[{"name":"Pathology Department, Instituto de Investigaci\u00f3n Sanitaria-Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3868-4896","authenticated-orcid":false,"given":"Miriam","family":"Morales-Gallego","sequence":"additional","affiliation":[{"name":"Pathology Department, Instituto de Investigaci\u00f3n Sanitaria-Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socorro Mar\u00eda","family":"Rodr\u00edguez-Pinilla","sequence":"additional","affiliation":[{"name":"Pathology Department, Instituto de Investigaci\u00f3n Sanitaria-Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantza","family":"Onaindia","sequence":"additional","affiliation":[{"name":"Pathology Department, Osakidetza Basque Health Service, Araba University Hospital, 01070 Vitoria-Gasteiz, Spain"},{"name":"Oncohaematology Research Group, Bioaraba Health Research Institute, 01070 Vitoria-Gasteiz, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","article-title":"Updated Kiel Classification for Lymphomas","volume":"1","author":"Stansfeld","year":"1988","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A Revised European-American Classification of Lymphoid Neoplasms: A Proposal from the International Lymphoma Study Group [See Comments]","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"ref_3","first-page":"343","article-title":"The Monoclonal Antibody ALK1 Identifies a Distinct Morphological Subtype of Anaplastic Large Cell Lymphoma Associated with 2p23\/ALK Rearrangements","volume":"151","author":"Pittaluga","year":"1997","journal-title":"Am. J. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood.V89.4.1394","article-title":"Detection of Anaplastic Lymphoma Kinase (ALK) and Nucleolar Protein Nucleophosmin (NPM)-ALK Proteins in Normal and Neoplastic Cells with the Monoclonal Antibody ALK1","volume":"89","author":"Pulford","year":"1997","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1038\/sj.onc.1204594","article-title":"Translocations Involving Anaplastic Lymphoma Kinase (ALK)","volume":"20","author":"Duyster","year":"2001","journal-title":"Oncogene"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/blood.V93.11.3913","article-title":"Prognostic Significance of Anaplastic Lymphoma Kinase (ALK) Protein Expression in Adults with Anaplastic Large Cell Lymphoma","volume":"93","author":"Gascoyne","year":"1999","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1182\/blood.V94.9.3265","article-title":"TRK-Fused Gene (TFG) Is a New Partner of ALK in Anaplastic Large Cell Lymphoma Producing Two Structurally Different TFG-ALK Translocations","volume":"94","author":"Pinyol","year":"1999","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/labinvest.3780249","article-title":"Molecular Characterization of a New ALK Translocation Involving Moesin (MSN-ALK) in Anaplastic Large Cell Lymphoma","volume":"81","author":"Tort","year":"2001","journal-title":"Lab. Investig."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/hon.660","article-title":"The New World Health Organization Classification of Lymphomas: The Past, the Present and the Future","volume":"19","author":"Chan","year":"2001","journal-title":"Hematol. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO Classification of Lymphoid Neoplasms and beyond: Evolving Concepts and Practical Applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 Revision of the World Health Organization Classification of Lymphoid Neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th Edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.848","article-title":"The Expression of the Hodgkin\u2019s Disease Associated Antigen Ki-1 in Reactive and Neoplastic Lymphoid Tissue: Evidence That Reed-Sternberg Cells and Histiocytic Malignancies Are Derived from Activated Lymphoid Cells","volume":"66","author":"Stein","year":"1985","journal-title":"Blood"},{"key":"ref_15","unstructured":"Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., and Thiele, J. (2017). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC. [4th ed.]."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Nakashima, M., and Uchimaru, K. (2023). CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia\/Lymphoma. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24108731"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.5858\/2001-125-1036-CEIFL","article-title":"CD30 Expression in Follicular Lymphoma","volume":"125","author":"Gardner","year":"2001","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Parente, P., Zanelli, M., Sanguedolce, F., Mastracci, L., and Graziano, P. (2020). Hodgkin Reed\u2013Sternberg-Like Cells in Non-Hodgkin Lymphoma. Diagnostics, 10.","DOI":"10.3390\/diagnostics10121019"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"100083","DOI":"10.1016\/j.modpat.2022.100083","article-title":"Frequent CD30 Expression in an Emerging Group of Mesenchymal Tumors With NTRK, BRAF, RAF1, or RET Fusions","volume":"36","author":"Kojima","year":"2023","journal-title":"Mod. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e23228","DOI":"10.1002\/gcc.23228","article-title":"CD30 Expression in an Emerging Group of Mesenchymal Spindle Cell Neoplasms with ALK Fusion Detected by Flow Cytometry and Immunohistochemistry","volume":"63","author":"Iwakoshi","year":"2024","journal-title":"Genes. Chromosomes Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.3324\/haematol.2013.084913","article-title":"CD30 Expression in Peripheral T-Cell Lymphomas","volume":"98","author":"Sabattini","year":"2013","journal-title":"Haematologica"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood-2014-07-584953","article-title":"Immunohistochemistry as a Valuable Tool to Assess CD30 Expression in Peripheral T-Cell Lymphomas: High Correlation with mRNA Levels","volume":"124","author":"Bossard","year":"2014","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.3324\/haematol.2015.135400","article-title":"Brentuximab Vedotin in Refractory or Relapsed Peripheral T-Cell Lymphomas: The French Named Patient Program Experience in 56 Patients","volume":"101","author":"Lamarque","year":"2016","journal-title":"Haematologica"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/bjh.16741","article-title":"Clinical and Pathological Characteristics of Peripheral T-Cell Lymphomas in a Spanish Population: A Retrospective Study","volume":"192","author":"Climent","year":"2021","journal-title":"Br. J. Haematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1440-1827.2007.02195.x","article-title":"Usefulness of Flow Cytometry for Differential Diagnosis of Precursor and Peripheral T-Cell and NK-Cell Lymphomas: Analysis of 490 Cases","volume":"58","author":"Karube","year":"2008","journal-title":"Pathol. Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3324\/haematol.2011.041079","article-title":"Cytotoxic Molecule-Positive Classical Hodgkin\u2019s Lymphoma: A Clinicopathological Comparison with Cytotoxic Molecule-Positive Peripheral T-Cell Lymphoma of Not Otherwise Specified Type","volume":"96","author":"Asano","year":"2011","journal-title":"Haematologica"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK- Anaplastic Large-Cell Lymphoma Is Clinically and Immunophenotypically Different from Both ALK+ ALCL and Peripheral T-Cell Lymphoma, Not Otherwise Specified: Report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Report of 340 Cases from the International Peripheral T-Cell Lymphoma Project","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3892\/ol.2017.5592","article-title":"Prognostic Significance of CD30 Expression in Nasal Natural Killer\/T-Cell Lymphoma","volume":"13","author":"Wang","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/hon.2482","article-title":"Frequent Expression of CD30 in Extranodal NK\/T-Cell Lymphoma: Potential Therapeutic Target for Anti-CD30 Antibody-Based Therapy","volume":"36","author":"Kawamoto","year":"2018","journal-title":"Hematol. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40880-017-0212-9","article-title":"CD30 Expression in Extranodal Natural Killer\/T-Cell Lymphoma, Nasal Type among 622 Cases of Mature T-Cell and Natural Killer-Cell Lymphoma at a Single Institution in South China","volume":"36","author":"Feng","year":"2017","journal-title":"Chin. J. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41379-018-0108-5","article-title":"CD30 Expression in Neoplastic T Cells of Follicular T Cell Lymphoma Is a Helpful Diagnostic Tool in the Differential Diagnosis of Hodgkin Lymphoma","volume":"32","author":"Hartmann","year":"2019","journal-title":"Mod. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/PAS.0000000000000571","article-title":"CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified","volume":"40","author":"Onaindia","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ajcp\/aqae012","article-title":"Clinicopathologic Features and Survival Outcomes of CD30 Expression in Extranodal Natural Killer\/T-Cell Lymphoma","volume":"162","author":"Shen","year":"2024","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/cas.15706","article-title":"The Oncogenic Driving Force of CD30 Signaling-Induced Chromosomal Instability in Adult T-Cell Leukemia\/Lymphoma","volume":"114","author":"Nakashima","year":"2023","journal-title":"Cancer Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"786","DOI":"10.4049\/jimmunol.165.2.786","article-title":"Engagement of CD153 (CD30 Ligand) by CD30+ T Cells Inhibits Class Switch DNA Recombination and Antibody Production in Human IgD+ IgM+ B Cells","volume":"165","author":"Cerutti","year":"2000","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1006\/smim.1998.0156","article-title":"CD30: Expression and Function in Health and Disease","volume":"10","author":"Horie","year":"1998","journal-title":"Semin. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-2836(02)01404-3","article-title":"TAK1 Is Critical for IkappaB Kinase-Mediated Activation of the NF-kappaB Pathway","volume":"326","author":"Takaesu","year":"2003","journal-title":"J. Mol. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"10252","DOI":"10.1074\/jbc.M608817200","article-title":"CD30 Activates Both the Canonical and Alternative NF-\u03baB Pathways in Anaplastic Large Cell Lymphoma Cells*","volume":"282","author":"Wright","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/s41375-020-01088-y","article-title":"A Novel Model of Alternative NF-\u03baB Pathway Activation in Anaplastic Large Cell Lymphoma","volume":"35","author":"Wang","year":"2021","journal-title":"Leukemia"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/labinvest.3700696","article-title":"Hypomethylation of CD30 CpG Islands with Aberrant JunB Expression Drives CD30 Induction in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma","volume":"88","author":"Watanabe","year":"2008","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/modpathol.3800419","article-title":"JunB Expression Is a Common Feature of CD30+ Lymphomas and Lymphomatoid Papulosis","volume":"18","author":"Rassidakis","year":"2005","journal-title":"Mod. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1093\/emboj\/cdf389","article-title":"Aberrantly Expressed C-Jun and JunB Are a Hallmark of Hodgkin Lymphoma Cells, Stimulate Proliferation and Synergize with NF-Kappa B","volume":"21","author":"Mathas","year":"2002","journal-title":"EMBO J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/01.pas.0000213412.25935.e4","article-title":"C-Jun Expression and Activation Are Restricted to CD30+ Lymphoproliferative Disorders","volume":"31","author":"Drakos","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1038\/s41467-021-25379-9","article-title":"Super-Enhancer-Based Identification of a BATF3\/IL-2R-Module Reveals Vulnerabilities in Anaplastic Large Cell Lymphoma","volume":"12","author":"Liang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cellsig.2009.12.008","article-title":"AP-1\u2014The Jun Proteins: Oncogenes or Tumor Suppressors in Disguise?","volume":"22","author":"Shaulian","year":"2010","journal-title":"Cell. Signal."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3324\/haematol.2020.263251","article-title":"Whole-Genome Profiling of Primary Cutaneous Anaplastic Large Cell Lymphoma","volume":"107","author":"Torres","year":"2022","journal-title":"Haematologica"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ccell.2018.06.014","article-title":"Targeting the HTLV-I-Regulated BATF3\/IRF4 Transcriptional Network in Adult T Cell Leukemia\/Lymphoma","volume":"34","author":"Nakagawa","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.1158\/1078-0432.CCR-18-0268","article-title":"CD30 Characterizes Polylobated Lymphocytes and Disease Progression in HTLV-1-Infected Individuals","volume":"24","author":"Nakashima","year":"2018","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.24086","article-title":"Non-Hodgkin Lymphoma Subtype Distribution, Geodemographic Patterns, and Survival in the US: A Longitudinal Analysis of the National Cancer Data Base from 1998 to 2011","volume":"90","author":"Habermann","year":"2015","journal-title":"Am. J. Hematol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/cncr.10396","article-title":"A Population-Based Study of Pediatric Anaplastic Large Cell Lymphoma","volume":"94","author":"Alessandri","year":"2002","journal-title":"Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41375-024-02468-4","article-title":"Comprehensive Genomic Analysis Reveals Molecular Heterogeneity in Pediatric ALK-Positive Anaplastic Large Cell Lymphoma","volume":"39","author":"Shaw","year":"2025","journal-title":"Leukemia"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1200\/JCO.2016.71.2083","article-title":"Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network","volume":"35","author":"Laurent","year":"2017","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International T-Cell Lymphoma Project International Peripheral T-Cell and Natural Killer\/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and Secondary Cutaneous CD30(+) Lymphoproliferative Disorders: A Report from the Dutch Cutaneous Lymphoma Group on the Long-Term Follow-up Data of 219 Patients and Guidelines for Diagnosis and Treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 Update of the WHO-EORTC Classification for Primary Cutaneous Lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2014-10-567461","article-title":"The Biology and Management of Systemic Anaplastic Large Cell Lymphoma","volume":"126","author":"Hapgood","year":"2015","journal-title":"Blood"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Zhang, X.-R., Chien, P.-N., Nam, S.-Y., and Heo, C.-Y. (2022). Anaplastic Large Cell Lymphoma: Molecular Pathogenesis and Treatment. Cancers, 14.","DOI":"10.3390\/cancers14071650"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Mussolin, L., Le Deley, M.-C., Carraro, E., Damm-Welk, C., Attarbaschi, A., Williams, D., Burke, A., Horibe, K., Nakazawa, A., and Wrobel, G. (2020). Prognostic Factors in Childhood Anaplastic Large Cell Lymphoma: Long Term Results of the International ALCL99 Trial. Cancers, 12.","DOI":"10.3390\/cancers12102747"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/ced.14777","article-title":"Primary Cutaneous Anaplastic Large-Cell Lymphoma: A Review of the SEER Database from 2005 to 2016","volume":"46","author":"Sarfraz","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.1172\/JCI134990","article-title":"ALK-Transformed Mature T Lymphocytes Restore Early Thymus Progenitor Features","volume":"130","author":"Congras","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"10087","DOI":"10.1038\/ncomms10087","article-title":"Anaplastic Large Cell Lymphoma Arises in Thymocytes and Requires Transient TCR Expression for Thymic Egress","volume":"7","author":"Malcolm","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/01.MP.0000021006.53593.B0","article-title":"Differential Expression of Thymus and Activation Regulated Chemokine and Its Receptor CCR4 in Nodal and Cutaneous Anaplastic Large-Cell Lymphomas and Hodgkin\u2019s Disease","volume":"15","author":"Vermeer","year":"2002","journal-title":"Mod. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.celrep.2016.09.018","article-title":"Insights into the Pathogenesis of Anaplastic Large-Cell Lymphoma through Genome-Wide DNA Methylation Profiling","volume":"17","author":"Hassler","year":"2016","journal-title":"Cell Rep."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Pina-Oviedo, S., Ortiz-Hidalgo, C., Carballo-Zarate, A.A., and Zarate-Osorno, A. (2021). ALK-Negative Anaplastic Large Cell Lymphoma: Current Concepts and Molecular Pathogenesis of a Heterogeneous Group of Large T-Cell Lymphomas. Cancers, 13.","DOI":"10.3390\/cancers13184667"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1182\/bloodadvances.2021005884","article-title":"Clonotype Pattern in T-Cell Lymphomas Map the Cell of Origin to Immature Lymphoid Precursors","volume":"6","author":"Iyer","year":"2022","journal-title":"Blood Adv."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.clml.2017.02.003","article-title":"Systemic Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: A Population-Based Analysis of Incidence and Survival","volume":"17","author":"Murthy","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"21","DOI":"10.12703\/r\/12-21","article-title":"ALK-Positive Anaplastic Large Cell Lymphoma in Adults","volume":"12","author":"Gromowsky","year":"2023","journal-title":"Fac. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.critrevonc.2012.02.005","article-title":"Anaplastic Large Cell Lymphoma, ALK-Positive","volume":"83","author":"Ferreri","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e1526","DOI":"10.1002\/cnr2.1526","article-title":"Immunophenotypic Shifts during Minimal Residual Evaluation in a Case of Leukemic Form of Anaplastic Large Cell Lymphoma ALK+","volume":"5","author":"Canellas","year":"2021","journal-title":"Cancer Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.humpath.2008.01.005","article-title":"Prevalence of Bone Marrow Involvement in Systemic Anaplastic Large Cell Lymphoma: Are Immunohistochemical Studies Necessary?","volume":"39","author":"Weinberg","year":"2008","journal-title":"Hum. Pathol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V91.6.2076","article-title":"ALK-Positive Lymphoma: A Single Disease With a Broad Spectrum of Morphology","volume":"91","author":"Benharroch","year":"1998","journal-title":"Blood"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2559.1990.tb01143.x","article-title":"Lymphohistiocytic T-Cell Lymphoma (Anaplastic Large Cell Lymphoma CD30+\/Ki-1 + with a High Content of Reactive Histiocytes)","volume":"16","author":"Pileri","year":"1990","journal-title":"Histopathology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30(+) Anaplastic Large Cell Lymphoma: A Review of Its Histopathologic, Genetic, and Clinical Features","volume":"96","author":"Stein","year":"2000","journal-title":"Blood"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3960\/jslrt.17023","article-title":"Anaplastic Large Cell Lymphoma: Pathology, Genetics, and Clinical Aspects","volume":"57","author":"Tsuyama","year":"2017","journal-title":"J. Clin. Exp. Hematop. JCEH"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41379-021-00944-1","article-title":"Small Cell\/Lymphohistiocytic Morphology Is Associated with Peripheral Blood Involvement, CD8 Positivity and Retained T-Cell Antigens, but Not Outcome in Adults with ALK+ Anaplastic Large Cell Lymphoma","volume":"35","author":"Khanlari","year":"2022","journal-title":"Mod. Pathol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12185-023-03553-7","article-title":"Transformation of Recurrent ALK-Positive Anaplastic Large-Cell Lymphoma from Common Pattern to Composite Pattern (Lymphohistiocytic and Small-Cell Pattern) with a Change in CD30 Expression","volume":"118","author":"Ji","year":"2023","journal-title":"Int. J. Hematol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0002-9440(10)65629-5","article-title":"ALK Expression Defines a Distinct Group of T\/Null Lymphomas (\u201cALK Lymphomas\u201d) with a Wide Morphological Spectrum","volume":"153","author":"Falini","year":"1998","journal-title":"Am. J. Pathol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"18525","DOI":"10.18632\/oncotarget.14503","article-title":"The Heterogeneous Landscape of ALK Negative ALCL","volume":"8","author":"Mereu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e562","DOI":"10.3324\/haematol.2018.213512","article-title":"ALK-Positive Anaplastic Large-Cell Lymphoma in Adults: An Individual Patient Data Pooled Analysis of 263 Patients","volume":"104","author":"Sibon","year":"2019","journal-title":"Haematologica"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1182\/blood-2023-186969","article-title":"Gene Expression Profiling Reveals Two Overarching Types of Anaplastic Large Cell Lymphoma with Distinct Targetable Biology: An L.L.M.P.P. Study","volume":"142","author":"Feldman","year":"2023","journal-title":"Blood"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1080\/10428194.2021.1881511","article-title":"PD-L1 Expression in Peripheral T-Cell Lymphomas Is Not Related to Either PD-L1 Gene Amplification or Rearrangements","volume":"62","author":"Manso","year":"2021","journal-title":"Leuk. Lymphoma"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Montes-Mojarro, I.A., Steinhilber, J., Bonzheim, I., Quintanilla-Martinez, L., and Fend, F. (2018). The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL). Cancers, 10.","DOI":"10.3390\/cancers10040107"},{"key":"ref_84","unstructured":"Kaseb, H., Mukkamalla, S.K.R., and Rajasurya, V. (2024). Anaplastic Large Cell Lymphoma. StatPearls, StatPearls Publishing."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2007.06924.x","article-title":"Genomic Profiling Reveals Different Genetic Aberrations in Systemic ALK-Positive and ALK-Negative Anaplastic Large Cell Lymphomas","volume":"140","author":"Salaverria","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2006-04-018770","article-title":"4q Loss Is Potentially an Important Genetic Event in MM Tumorigenesis: Identification of a Tumor Suppressor Gene Regulated by Promoter Methylation at 4q13.3, Platelet Factor 4","volume":"109","author":"Cheng","year":"2007","journal-title":"Blood"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/ajcp\/aqx139","article-title":"The 11q-Gain\/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS","volume":"149","author":"Grygalewicz","year":"2018","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41375-020-01093-1","article-title":"STAT3 and TP53 Mutations Associate with Poor Prognosis in Anaplastic Large Cell Lymphoma","volume":"35","author":"Lobello","year":"2021","journal-title":"Leukemia"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40164-021-00200-x","article-title":"Correlation of Mutational Landscape and Survival Outcome of Peripheral T-Cell Lymphomas","volume":"10","author":"Ye","year":"2021","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Cela, I., Di Matteo, A., and Federici, L. (2020). Nucleophosmin in Its Interaction with Ligands. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21144885"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a Kinase Gene, ALK, to a Nucleolar Protein Gene, NPM, in Non-Hodgkin\u2019s Lymphoma","volume":"263","author":"Morris","year":"1994","journal-title":"Science"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Wu, R., and Lim, M.S. (2023). Updates in Pathobiological Aspects of Anaplastic Large Cell Lymphoma. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1241532"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.leukres.2007.07.012","article-title":"Analysis of Gene Expression Profile of TPM3-ALK Positive Anaplastic Large Cell Lymphoma Reveals Overlapping and Unique Patterns with That of NPM-ALK Positive Anaplastic Large Cell Lymphoma","volume":"32","author":"Bohling","year":"2008","journal-title":"Leuk. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"100428","DOI":"10.1016\/j.modpat.2024.100428","article-title":"Molecular Screening in Anaplastic Lymphoma Kinase\u2013Positive Anaplastic Large Cell Lymphoma: Anaplastic Lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling","volume":"37","author":"Kalinova","year":"2024","journal-title":"Mod. Pathol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1128\/MCB.18.12.6951","article-title":"Nucleophosmin-Anaplastic Lymphoma Kinase of Large-Cell Anaplastic Lymphoma Is a Constitutively Active Tyrosine Kinase That Utilizes Phospholipase C-Gamma to Mediate Its Mitogenicity","volume":"18","author":"Bai","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1182\/blood.V96.13.4319","article-title":"Nucleophosmin-Anaplastic Lymphoma Kinase Associated with Anaplastic Large-Cell Lymphoma Activates the Phosphatidylinositol 3-Kinase\/Akt Antiapoptotic Signaling Pathway","volume":"96","author":"Bai","year":"2000","journal-title":"Blood"},{"key":"ref_97","first-page":"2194","article-title":"Role of Phosphatidylinositol 3-Kinase-Akt Pathway in Nucleophosmin\/Anaplastic Lymphoma Kinase-Mediated Lymphomagenesis","volume":"61","author":"Slupianek","year":"2001","journal-title":"Cancer Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/blood-2015-11-683052","article-title":"Redundant and Nonredundant Roles for Cdc42 and Rac1 in Lymphomas Developed in NPM-ALK Transgenic Mice","volume":"127","author":"Choudhari","year":"2016","journal-title":"Blood"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1182\/blood-2006-11-059451","article-title":"NPM-ALK Oncogenic Kinase Promotes Cell-Cycle Progression through Activation of JNK\/cJun Signaling in Anaplastic Large-Cell Lymphoma","volume":"110","author":"Leventaki","year":"2007","journal-title":"Blood"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4049\/jimmunol.168.1.466","article-title":"Multilevel Dysregulation of STAT3 Activation in Anaplastic Lymphoma Kinase-Positive T\/Null-Cell Lymphoma","volume":"168","author":"Zhang","year":"2002","journal-title":"J. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1182\/blood-2009-02-204735","article-title":"The Proteomic Signature of NPM\/ALK Reveals Deregulation of Multiple Cellular Pathways","volume":"114","author":"Lim","year":"2009","journal-title":"Blood"},{"key":"ref_102","first-page":"6517","article-title":"Role of Signal Transducer and Activator of Transcription 5 in Nucleophosmin\/Anaplastic Lymphoma Kinase-Mediated Malignant Transformation of Lymphoid Cells","volume":"61","author":"Slupianek","year":"2001","journal-title":"Cancer Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"8611","DOI":"10.1158\/0008-5472.CAN-09-2655","article-title":"NPM-ALK Oncogenic Tyrosine Kinase Controls T-Cell Identity by Transcriptional Regulation and Epigenetic Silencing in Lymphoma Cells","volume":"69","author":"Ambrogio","year":"2009","journal-title":"Cancer Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.onc.1205152","article-title":"Anaplastic Lymphoma Kinase (ALK) Activates Stat3 and Protects Hematopoietic Cells from Cell Death","volume":"21","author":"Zamo","year":"2002","journal-title":"Oncogene"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3324\/haematol.2009.014050","article-title":"C\/EBP\u03b2 Expression in ALK-Positive Anaplastic Large Cell Lymphomas Is Required for Cell Proliferation and Is Induced by the STAT3 Signaling Pathway","volume":"95","author":"Anastasov","year":"2010","journal-title":"Haematologica"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood-2016-05-717793","article-title":"Nucleophosmin-Anaplastic Lymphoma Kinase: The Ultimate Oncogene and Therapeutic Target","volume":"129","author":"Werner","year":"2017","journal-title":"Blood"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4161\/cc.4.9.1985","article-title":"New and Old Functions of STAT3: A Pivotal Target for Individualized Treatment of Cancer","volume":"4","author":"Inghirami","year":"2005","journal-title":"Cell Cycle Georget. Tex"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm1249","article-title":"Stat3 Is Required for ALK-Mediated Lymphomagenesis and Provides a Possible Therapeutic Target","volume":"11","author":"Chiarle","year":"2005","journal-title":"Nat. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.4049\/jimmunol.1300744","article-title":"Malignant Transformation of CD4+ T Lymphocytes Mediated by Oncogenic Kinase NPM\/ALK Recapitulates IL-2-Induced Cell Signaling and Gene Expression Reprogramming","volume":"191","author":"Marzec","year":"2013","journal-title":"J. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.cellsig.2012.02.007","article-title":"Regulation of C\/EBP\u03b2 and Resulting Functions in Cells of the Monocytic Lineage","volume":"24","author":"Huber","year":"2012","journal-title":"Cell. Signal."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Bonzheim, I., Irmler, M., Klier-Richter, M., Steinhilber, J., Anastasov, N., Sch\u00e4fer, S., Adam, P., Beckers, J., Raffeld, M., and Fend, F. (2013). Identification of C\/EBP\u03b2 Target Genes in ALK+ Anaplastic Large Cell Lymphoma (ALCL) by Gene Expression Profiling and Chromatin Immunoprecipitation. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0064544"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/blood-2005-10-014258","article-title":"NPM-ALK-Dependent Expression of the Transcription Factor CCAAT\/Enhancer Binding Protein Beta in ALK-Positive Anaplastic Large Cell Lymphoma","volume":"108","author":"Pittaluga","year":"2006","journal-title":"Blood"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1182\/blood-2014-08-594507","article-title":"Essential Role of IRF4 and MYC Signaling for Survival of Anaplastic Large Cell Lymphoma","volume":"125","author":"Weilemann","year":"2015","journal-title":"Blood"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/leu.2017.203","article-title":"An Oncogenic Axis of STAT-Mediated BATF3 Upregulation Causing MYC Activity in Classical Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma","volume":"32","author":"Lollies","year":"2018","journal-title":"Leukemia"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood.2022018494","article-title":"SBNO2 Is a Critical Mediator of STAT3-Driven Hematological Malignancies","volume":"141","author":"Brandstoetter","year":"2023","journal-title":"Blood"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/s41416-024-02881-7","article-title":"Recurrent Somatic Mutations of FAT Family Cadherins Induce an Aggressive Phenotype and Poor Prognosis in Anaplastic Large Cell Lymphoma","volume":"131","author":"Villa","year":"2024","journal-title":"Br. J. Cancer"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13148-025-01816-0","article-title":"TET2-Mediated 5-Hydroxymethylcytosine of TXNIP Promotes Cell Cycle Arrest in Systemic Anaplastic Large Cell Lymphoma","volume":"17","author":"Yu","year":"2025","journal-title":"Clin. Epigenetics"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"16228","DOI":"10.1073\/pnas.1009719107","article-title":"Identification of Differential and Functionally Active miRNAs in Both Anaplastic Lymphoma Kinase (ALK)+ and ALK- Anaplastic Large-Cell Lymphoma","volume":"107","author":"Merkel","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3324\/haematol.2013.088286","article-title":"STAT3-Mediated Activation of microRNA Cluster 17~92 Promotes Proliferation and Survival of ALK-Positive Anaplastic Large Cell Lymphoma","volume":"99","author":"Spaccarotella","year":"2014","journal-title":"Haematologica"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2174\/138161209787315837","article-title":"MicroRNA Involvement in the Pathogenesis of Neuroblastoma: Potential for microRNA Mediated Therapeutics","volume":"15","author":"Stallings","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1158\/1535-7163.MCT-11-0042","article-title":"European Research Initiative on Anaplastic Large Cell Lymphoma Novel Therapeutic Options in Anaplastic Large Cell Lymphoma: Molecular Targets and Immunological Tools","volume":"10","author":"Merkel","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Steinhilber, J., Bonin, M., Walter, M., Fend, F., Bonzheim, I., and Quintanilla-Martinez, L. (2015). Next-Generation Sequencing Identifies Deregulation of microRNAs Involved in Both Innate and Adaptive Immune Response in ALK+ ALCL. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117780"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1182\/blood-2011-05-354654","article-title":"miR-135b Mediates NPM-ALK-Driven Oncogenicity and Renders IL-17-Producing Immunophenotype to Anaplastic Large Cell Lymphoma","volume":"118","author":"Matsuyama","year":"2011","journal-title":"Blood"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1172\/JCI78488","article-title":"Reversal of microRNA-150 Silencing Disadvantages Crizotinib-Resistant NPM-ALK(+) Cell Growth","volume":"125","author":"Valentin","year":"2015","journal-title":"J. Clin. Invest."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Garbin, A., Contarini, G., Damanti, C.C., Tosato, A., Bortoluzzi, S., Gaffo, E., Pizzi, M., Carraro, E., Lo Nigro, L., and Vinti, L. (2023). MiR-146a-5p Enrichment in Small-Extracellular Vesicles of Relapsed Pediatric ALCL Patients Promotes Macrophages Infiltration and Differentiation. Biochem. Pharmacol., 215.","DOI":"10.1016\/j.bcp.2023.115747"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Chung, I.-H., Lu, P.-H., Lin, Y.-H., Tsai, M.-M., Lin, Y.-W., Chiu, C.-T., and Lin, K.-H. (2017). The Long Non-Coding RNA LINC01013 Enhances Invasion of Human Anaplastic Large-Cell Lymphoma. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-00382-7"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/15680096113136660102","article-title":"The Role of Snail in EMT and Tumorigenesis","volume":"13","author":"Wang","year":"2013","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ccr.2005.07.009","article-title":"The Transcriptional Repressor Snail Promotes Mammary Tumor Recurrence","volume":"8","author":"Moody","year":"2005","journal-title":"Cancer Cell"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.isci.2018.06.007","article-title":"Chromosomal Translocation Formation Is Sufficient to Produce Fusion Circular RNAs Specific to Patient Tumor Cells","volume":"5","author":"Babin","year":"2018","journal-title":"iScience"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/wrna.1284","article-title":"The Emerging Landscape of Small Nucleolar RNAs in Cell Biology","volume":"6","author":"Poirier","year":"2015","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1182\/blood-2012-06-438135","article-title":"Small Nucleolar RNA Expression Profiling Identifies Potential Prognostic Markers in Peripheral T-Cell Lymphoma","volume":"120","author":"Valleron","year":"2012","journal-title":"Blood"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1182\/blood-2007-07-100958","article-title":"European Intergroup for Childhood Non-Hodgkin Lymphoma Prognostic Factors in Childhood Anaplastic Large Cell Lymphoma: Results of a Large European Intergroup Study","volume":"111","author":"Reiter","year":"2008","journal-title":"Blood"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1002\/pbc.24591","article-title":"Central Nervous System Involvement in Anaplastic Large Cell Lymphoma in Childhood: Results from a Multicentre European and Japanese Study","volume":"60","author":"Williams","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/bjh.12777","article-title":"Paediatric Anaplastic Large Cell Lymphoma with Leukaemic Presentation in Children: A Report of Nine French Cases","volume":"165","author":"Spiegel","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1309\/WH8PNU9PK4RRV852","article-title":"ALK-Positive Anaplastic Large Cell Lymphoma with Leukemic Peripheral Blood Involvement Is a Clinicopathologic Entity with an Unfavorable Prognosis. Report of Three Cases and Review of the Literature","volume":"120","author":"Onciu","year":"2003","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00277-007-0289-3","article-title":"Highly Aggressive ALK-Positive Anaplastic Large Cell Lymphoma with a Leukemic Phase and Multi-Organ Involvement: A Report of Three Cases and a Review of the Literature","volume":"86","author":"Grewal","year":"2007","journal-title":"Ann. Hematol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s00277-025-06297-y","article-title":"TP53 Deletion Is Associated with Poor Survival of Adult ALK-Positive ALCL Patients Receiving CHOP-Based Chemotherapy","volume":"104","author":"Katagiri","year":"2025","journal-title":"Ann. Hematol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1200\/JCO.2011.36.5411","article-title":"Prognostic Impact of Morphologic and Phenotypic Features of Childhood ALK-Positive Anaplastic Large-Cell Lymphoma: Results of the ALCL99 Study","volume":"29","author":"Lamant","year":"2011","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/bjh.17776","article-title":"Characterisation of Two Tumour Cell Populations in the Small Cell Variant of Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma","volume":"196","author":"Noguchi","year":"2022","journal-title":"Br. J. Haematol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.3324\/haematol.2019.232314","article-title":"Quantification of Minimal Disseminated Disease by Quantitative Polymerase Chain Reaction and Digital Polymerase Chain Reaction for NPM-ALK as a Prognostic Factor in Children with Anaplastic Large Cell Lymphoma","volume":"105","author":"Kutscher","year":"2020","journal-title":"Haematologica"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood.2020009806","article-title":"Brentuximab Vedotin in Combination with Chemotherapy for Pediatric Patients with ALK+ ALCL: Results of COG Trial ANHL12P1","volume":"137","author":"Lowe","year":"2021","journal-title":"Blood"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pathol.2019.08.013","article-title":"Diffuse Large B-Cell Lymphoma Variants: An Update","volume":"52","author":"Sukswai","year":"2020","journal-title":"Pathology"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1182\/blood.V89.5.1483","article-title":"A New Subtype of Large B-Cell Lymphoma Expressing the ALK Kinase and Lacking the 2; 5 Translocation","volume":"89","author":"Delsol","year":"1997","journal-title":"Blood"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/PAS.0000000000000753","article-title":"ALK-Positive Large B-Cell Lymphoma: A Clinicopathologic Study of 26 Cases with Review of Additional 108 Cases in the Literature","volume":"41","author":"Pan","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1200\/JCO.2008.21.5020","article-title":"Anaplastic Lymphoma Kinase\u2013Positive Diffuse Large B-Cell Lymphoma: A Rare Clinicopathologic Entity with Poor Prognosis","volume":"27","author":"Laurent","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jama.2019.11058","article-title":"Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review","volume":"322","author":"Arbour","year":"2019","journal-title":"JAMA"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.advms.2022.02.002","article-title":"What Do We Know about Inflammatory Myofibroblastic Tumors?\u2014A Systematic Review","volume":"67","author":"Siemion","year":"2022","journal-title":"Adv. Med. Sci."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.2021013338","article-title":"ALK-Positive Histiocytosis: A New Clinicopathologic Spectrum Highlighting Neurologic Involvement and Responses to ALK Inhibition","volume":"139","author":"Kemps","year":"2022","journal-title":"Blood"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Veija, T., Koljonen, V., Bohling, T., Kero, M., Knuutila, S., and Sarhadi, V.K. (2017). Aberrant Expression of ALK and EZH2 in Merkel Cell Carcinoma. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3233-5"},{"key":"ref_150","first-page":"100538","article-title":"Successful Treatment of ALK-Positive Large-Cell Neuroendocrine Carcinoma of the Lung with Sequential ALK Inhibitors: A Case Report","volume":"4","author":"Kobayashi","year":"2023","journal-title":"JTO Clin. Res. Rep."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/PAS.0000000000000611","article-title":"Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation","volume":"40","author":"Busam","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/PAS.0000000000000387","article-title":"Clinical, Histopathologic and Genomic Features of Spitz Tumors with ALK Fusions","volume":"39","author":"Yeh","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1038\/s41379-020-0578-0","article-title":"ALK Rearranged Renal Cell Carcinoma (ALK-RCC): A Multi-Institutional Study of Twelve Cases with Identification of Novel Partner Genes CLIP1, KIF5B and KIAA1217","volume":"33","author":"Kuroda","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12308-023-00537-8","article-title":"Epithelioid Inflammatory Myofibroblastic Sarcoma: A Pitfall in the Differential Diagnosis of ALK-Positive Anaplastic Large Cell Lymphoma","volume":"16","author":"Fadl","year":"2023","journal-title":"J. Hematop."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"178","DOI":"10.21037\/tp-23-603","article-title":"Pediatric Spindle Cell\/Sclerosing Rhabdomyosarcoma with FUS\u2013TFCP2 Fusion: A Case Report and Literature Review","volume":"13","author":"Fang","year":"2024","journal-title":"Transl. Pediatr."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1158\/2159-8290.CD-12-0009","article-title":"ALKoma: A Cancer Subtype with a Shared Target","volume":"2","author":"Mano","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc3580","article-title":"Mechanistic Insight into ALK Receptor Tyrosine Kinase in Human Cancer Biology","volume":"13","author":"Hallberg","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.critrevonc.2012.06.004","article-title":"Anaplastic Large Cell Lymphoma, ALK-Negative","volume":"85","author":"Ferreri","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13000-025-01597-3","article-title":"Synchronous Clonally Related Anaplastic Large Cell Lymphoma and Malignant Histiocytosis","volume":"20","author":"Harb","year":"2025","journal-title":"Diagn. Pathol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1182\/blood-2004-03-1037","article-title":"Anaplastic Large Cell Lymphomas Lack the Expression of T-Cell Receptor Molecules or Molecules of Proximal T-Cell Receptor Signaling","volume":"104","author":"Bonzheim","year":"2004","journal-title":"Blood"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1182\/blood.V89.3.980","article-title":"Cytotoxic Cell Antigen Expression in Anaplastic Large Cell Lymphomas of T- and Null-Cell Type and Hodgkin\u2019s Disease: Evidence for Distinct Cellular Origin","volume":"89","author":"Krenacs","year":"1997","journal-title":"Blood"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1182\/blood.V88.10.4005.bloodjournal88104005","article-title":"Anaplastic Large-Cell Lymphomas of T-Cell and Null-Cell Phenotype Express Cytotoxic Molecules","volume":"88","author":"Foss","year":"1996","journal-title":"Blood"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-Negative Anaplastic Large Cell Lymphoma Is a Genetically Heterogeneous Disease with Widely Disparate Clinical Outcomes","volume":"124","author":"Jaffe","year":"2014","journal-title":"Blood"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2020.01.005","article-title":"CD8 Expression in Anaplastic Large Cell Lymphoma Correlates with Noncommon Morphologic Variants and T-Cell Antigen Expression Suggesting Biological Differences with CD8-Negative Anaplastic Large Cell Lymphoma","volume":"98","author":"Shen","year":"2020","journal-title":"Hum. Pathol."},{"key":"ref_165","first-page":"100","article-title":"Epstein-Barr Virus Positive Anaplastic Large Cell Lymphoma: Myth or Reality?","volume":"4","author":"Ma","year":"2011","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1365-4632.2006.02951.x","article-title":"Epstein\u2013Barr Virus in CD30+ Anaplastic Large Cell Lymphoma Involving the Skin and Lymphomatoid Papulosis in South Korea","volume":"45","author":"Kim","year":"2006","journal-title":"Int. J. Dermatol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/1066896916683447","article-title":"PAX-5 Positivity in Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma: A Case Report and Review of Literature","volume":"25","author":"Arun","year":"2017","journal-title":"Int. J. Surg. Pathol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/modpathol.2010.4","article-title":"PAX5-Positive T-Cell Anaplastic Large Cell Lymphomas Associated with Extra Copies of the PAX5 Gene Locus","volume":"23","author":"Feldman","year":"2010","journal-title":"Mod. Pathol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"bcr2015211159","DOI":"10.1136\/bcr-2015-211159","article-title":"PAX5-Expressing ALK-Negative Anaplastic Large Cell Lymphoma with Extensive Extranodal and Nodal Involvement","volume":"2015","author":"Ong","year":"2015","journal-title":"BMJ Case Rep."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"E395","DOI":"10.1002\/dc.24821","article-title":"ALK-Negative Anaplastic Large Cell Lymphoma, Null Type with Aberrant Expression of PAX5 and CD138: A Diagnostic Pitfall","volume":"49","author":"Salyana","year":"2021","journal-title":"Diagn. Cytopathol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/PAS.0000000000001941","article-title":"Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell Lymphoma","volume":"46","author":"Feldman","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0002-9440(10)63742-X","article-title":"Genomic Profiling of Peripheral T-Cell Lymphoma, Unspecified, and Anaplastic Large T-Cell Lymphoma Delineates Novel Recurrent Chromosomal Alterations","volume":"164","author":"Zettl","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1182\/blood-2013-04-497933","article-title":"PRDM1\/BLIMP1 Is Commonly Inactivated in Anaplastic Large T-Cell Lymphoma","volume":"122","author":"Boi","year":"2013","journal-title":"Blood"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/modpathol.3800299","article-title":"Extra Copies of Chromosome 2 Are a Recurring Aberration in ALK-Negative Lymphomas with Anaplastic Morphology","volume":"18","author":"Kansal","year":"2005","journal-title":"Mod. Pathol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood-2018-03-838524","article-title":"Molecular Profiling Reveals Immunogenic Cues in Anaplastic Large Cell Lymphomas with DUSP22 Rearrangements","volume":"132","author":"Luchtel","year":"2018","journal-title":"Blood"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of Recurrent t(6;7)(P25.3;Q32.3) Translocations in ALK-Negative Anaplastic Large Cell Lymphomas by Massively Parallel Genomic Sequencing","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.3324\/haematol.2018.205880","article-title":"DUSP22-Rearranged Anaplastic Lymphomas Are Characterized by Specific Morphological Features and a Lack of Cytotoxic and JAK\/STAT Surrogate Markers","volume":"104","author":"Onaindia","year":"2019","journal-title":"Haematologica"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0000000000000500","article-title":"Morphologic Features of ALK-Negative Anaplastic Large Cell Lymphomas with DUSP22 Rearrangements","volume":"40","author":"King","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/PAS.0000000000001614","article-title":"Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma","volume":"45","author":"Ravindran","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.humpath.2023.04.015","article-title":"Anaplastic Large Cell Lymphomas with the 6p25.3 Rearrangement Are a Heterogeneous Group of Tumours with a Diverse Molecular Background","volume":"137","author":"Salgado","year":"2023","journal-title":"Hum. Pathol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.humpath.2023.08.007","article-title":"Anaplastic Large Cell Lymphomas with Equivocal DUSP22 FISH Results: Recommendations for Clinical Reporting and Diagnostic Evaluation","volume":"141","author":"Fadl","year":"2023","journal-title":"Hum. Pathol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.humpath.2017.01.003","article-title":"Expression of P63 Protein in Anaplastic Large Cell Lymphoma: Implications for Genetic Subtyping","volume":"64","author":"Wang","year":"2017","journal-title":"Hum. Pathol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-Wide Analysis Reveals Recurrent Structural Abnormalities of TP63 and Other P53-Related Genes in Peripheral T-Cell Lymphomas","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Woodstock, D.L., Sammons, M.A., and Fischer, M. (2021). P63 and P53: Collaborative Partners or Dueling Rivals?. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.701986"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Xu, Y., Xiong, Q., Han, J., and Zhu, Q. (2023). The Dual Role of P63 in Cancer. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1116061"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"eadi7244","DOI":"10.1126\/scitranslmed.adi7244","article-title":"TP63 Fusions Drive Multicomplex Enhancer Rewiring, Lymphomagenesis, and EZH2 Dependence","volume":"15","author":"Wu","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1111\/bjh.15860","article-title":"Identification of High-Risk DUSP22-Rearranged ALK-Negative Anaplastic Large Cell Lymphoma","volume":"186","author":"Hapgood","year":"2019","journal-title":"Br. J. Haematol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/PAS.0000000000001995","article-title":"JAK\/STAT3 Signaling Activation Related to Distinct Clinicopathologic Features in Systemic ALK-Anaplastic Large Cell Lymphomas: New Insights into Their Heterogeneity","volume":"47","author":"Wang","year":"2023","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1182\/blood.2019004164","article-title":"\u201cDouble-Hit\u201d of DUSP22 and TP63 Rearrangements in Anaplastic Large Cell Lymphoma, ALK-Negative","volume":"135","author":"Karube","year":"2020","journal-title":"Blood"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/10428194.2021.1984457","article-title":"Co-Occurring Rearrangements of DUSP22 and TP63 Define a Rare Genetic Subset of ALK-Negative Anaplastic Large Cell Lymphoma with Inferior Survival Outcomes","volume":"63","author":"Klairmont","year":"2022","journal-title":"Leuk. Lymphoma"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PAS.0000000000001708","article-title":"JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas with Anaplastic Morphology","volume":"45","author":"Fitzpatrick","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1182\/blood-2014-12-614503","article-title":"Identification of a New Subclass of ALK-Negative ALCL Expressing Aberrant Levels of ERBB4 Transcripts","volume":"127","author":"Pellegrino","year":"2016","journal-title":"Blood"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/leu.2017.309","article-title":"Targetable Fusions of the FRK Tyrosine Kinase in ALK-Negative Anaplastic Large Cell Lymphoma","volume":"32","author":"Hu","year":"2018","journal-title":"Leukemia"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1111\/bjh.17169","article-title":"Anaplastic Lymphoma Kinase (ALK)-Negative Anaplastic Large Cell Lymphoma with MYC Rearrangement","volume":"192","author":"Khanlari","year":"2021","journal-title":"Br. J. Haematol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.20110283","article-title":"Somatic Mutations Activating STAT3 in Human Inflammatory Hepatocellular Adenomas","volume":"208","author":"Pilati","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1182\/blood-2013-04-494930","article-title":"STAT3 Mutations Indicate the Presence of Subclinical T-Cell Clones in a Subset of Aplastic Anemia and Myelodysplastic Syndrome Patients","volume":"122","author":"Jerez","year":"2013","journal-title":"Blood"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1073\/pnas.1700682114","article-title":"Cytokine Receptor Signaling Is Required for the Survival of ALK- Anaplastic Large Cell Lymphoma, Even in the Presence of JAK1\/STAT3 Mutations","volume":"114","author":"Chen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood.V128.22.461.461","article-title":"Novel Long Non Coding RNA Blackmamba Is Associated to ALK- Anaplastic Large Cell Lymphoma","volume":"128","author":"Fragliasso","year":"2016","journal-title":"Blood"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.3324\/haematol.2022.282552","article-title":"Long Non-Coding RNA Mitophagy and ALK-Negative Anaplastic Lymphoma-Associated Transcript: A Novel Regulator of Mitophagy in T-Cell Lymphoma","volume":"108","author":"Mularoni","year":"2023","journal-title":"Haematologica"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Huang, P.-S., Chung, I.-H., Lin, Y.-H., Lin, T.-K., Chen, W.-J., and Lin, K.-H. (2018). The Long Non-Coding RNA MIR503HG Enhances Proliferation of Human ALK-Negative Anaplastic Large-Cell Lymphoma. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19051463"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1182\/blood.2019000626","article-title":"Recurrent MSC E116K Mutations in ALK-Negative Anaplastic Large Cell Lymphoma","volume":"133","author":"Luchtel","year":"2019","journal-title":"Blood"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/sj.leu.2403840","article-title":"P53 Gene Mutations Are Uncommon but P53 Is Commonly Expressed in Anaplastic Large-Cell Lymphoma","volume":"19","author":"Rassidakis","year":"2005","journal-title":"Leukemia"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/cncr.22718","article-title":"Germline Mutations of the Perforin Gene Are a Frequent Occurrence in Childhood Anaplastic Large Cell Lymphoma","volume":"109","author":"Cannella","year":"2007","journal-title":"Cancer"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/pin.12758","article-title":"Anaplastic Large Cell Lymphoma with TP63 Rearrangement: A Dismal Prognosis","volume":"69","author":"Yamashita","year":"2019","journal-title":"Pathol. Int."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood.V130.Suppl_1.822.822","article-title":"The Impact of Upfront Autologous Transplant on the Survival of Adult Patients with ALCL and PTCL-NOS According to Their ALK, DUSP22 and TP63 Gene Rearrangement Status-a Joined Nordic Lymphoma Group and Mayo Clinic Analysis","volume":"130","author":"Pedersen","year":"2017","journal-title":"Blood"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","article-title":"Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01","volume":"30","author":"Relander","year":"2012","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2016-12-755496","article-title":"DUSP22 and TP63 Rearrangements Predict Outcome of ALK-Negative Anaplastic Large Cell Lymphoma: A Danish Cohort Study","volume":"130","author":"Pedersen","year":"2017","journal-title":"Blood"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"123","DOI":"10.6004\/jnccn.2018.0007","article-title":"NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018","volume":"16","author":"Horwitz","year":"2018","journal-title":"J. Natl. Compr. Cancer Netw. JNCCN"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3324\/haematol.2022.281222","article-title":"DUSP22 Rearrangement Is Associated with a Distinctive Immunophenotype but Not Outcome in Patients with Systemic ALK-Negative Anaplastic Large Cell Lymphoma","volume":"108","author":"Qiu","year":"2022","journal-title":"Haematologica"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene Expression Signatures Delineate Biological and Prognostic Subgroups in Peripheral T-Cell Lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1182\/blood-2012-01-405555","article-title":"Identification of a 3-Gene Model as a Powerful Diagnostic Tool for the Recognition of ALK-Negative Anaplastic Large-Cell Lymphoma","volume":"120","author":"Agnelli","year":"2012","journal-title":"Blood"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2006-06-028969","article-title":"Gene-Expression Profiling of Systemic Anaplastic Large-Cell Lymphoma Reveals Differences Based on ALK Status and Two Distinct Morphologic ALK+ Subtypes","volume":"109","author":"Lamant","year":"2007","journal-title":"Blood"},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Xiang, C., Wu, W., Fan, M., Wang, Z., Feng, X., Liu, C., Liu, J., Liu, G., Xia, L., and Si, H. (2023). Phosphorylated STAT3 as a Potential Diagnostic and Predictive Biomarker in ALK- ALCL vs. CD30high PTCL, NOS. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1132834"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"NP253","DOI":"10.1093\/asj\/sjz044","article-title":"The First Reported Case of Gluteal Implant-Associated Anaplastic Large Cell Lymphoma (ALCL)","volume":"39","author":"Shauly","year":"2019","journal-title":"Aesthet. Surg. J."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1093\/asj\/sjad181","article-title":"BIA-ALCL Epidemiology in an Aesthetic Breast Surgery Cohort of 1501 Patients","volume":"43","author":"Sorotos","year":"2023","journal-title":"Aesthet. Surg. J."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/asj\/sjac312","article-title":"BIA-ALCL Epidemiological Findings From a Retrospective Study of 248 Cases Extracted from Relevant Case Reports and Series: A Systematic Review","volume":"43","author":"Panagiotakos","year":"2023","journal-title":"Aesthet. Surg. J."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/PRS.0000000000001033","article-title":"Anaplastic Large Cell Lymphoma Occurring in Women with Breast Implants: Analysis of 173 Cases","volume":"135","author":"Brody","year":"2015","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/annonc\/mdv575","article-title":"Breast Implant-Associated Anaplastic Large Cell Lymphoma: Two Distinct Clinicopathological Variants with Different Outcomes","volume":"27","author":"Laurent","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4274\/ejbh.galenos.2021.2021-5-6","article-title":"New Data on the Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma","volume":"17","author":"Ionescu","year":"2021","journal-title":"Eur. J. Breast Health"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jso.25626","article-title":"Breast Implant-Associated Anaplastic Large Cell Lymphoma, a Systematic Review and in-Depth Evaluation of the Current Understanding","volume":"120","author":"Ebner","year":"2019","journal-title":"J. Surg. Oncol."},{"key":"ref_222","first-page":"628","article-title":"Breast Implant-Associated Lymphoma","volume":"115","author":"Kricheldorff","year":"2018","journal-title":"Dtsch. Arzteblatt Int."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/SLA.0000000000004179","article-title":"Breast Implant-Associated Anaplastic Large Cell Lymphoma Incidence: Determining an Accurate Risk","volume":"272","author":"Nelson","year":"2020","journal-title":"Ann. Surg."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41379-018-0134-3","article-title":"Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Review","volume":"32","author":"Quesada","year":"2019","journal-title":"Mod. Pathol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/PRS.0000000000008155","article-title":"An Unusual Case of BIA-ALCL Associated with Prolonged\/Complicated Biocell-Textured Expander, Followed by Smooth Round Breast Implant Exposure, and Concurrent Use of Adalimumab","volume":"148","author":"Akhavan","year":"2021","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Di Napoli, A., Pepe, G., Giarnieri, E., Cippitelli, C., Bonifacino, A., Mattei, M., Martelli, M., Falasca, C., Cox, M.C., and Santino, I. (2017). Cytological Diagnostic Features of Late Breast Implant Seromas: From Reactive to Anaplastic Large Cell Lymphoma. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181097"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/1066896915579103","article-title":"Axillary Lymphadenopathy: An Outstanding Presentation for Breast Implant-Associated ALK-Negative Anaplastic Large Cell Lymphoma","volume":"23","author":"Granados","year":"2015","journal-title":"Int. J. Surg. Pathol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAS.0000000000000985","article-title":"Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-Associated Anaplastic Large Cell Lymphoma","volume":"42","author":"Medeiros","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.breast.2022.11.009","article-title":"Clinical Recommendations for Diagnosis and Treatment According to Current Updated Knowledge on BIA-ALCL","volume":"66","author":"Longo","year":"2022","journal-title":"Breast Edinb. Scotl."},{"key":"ref_230","first-page":"79","article-title":"Current Updates on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)","volume":"32","author":"Ghione","year":"2019","journal-title":"Rev. Senol. Patol. Mamar."},{"key":"ref_231","first-page":"4700787","article-title":"An Unusual Case of Breast Implant-Associated Anaplastic Large Cell Lymphoma","volume":"2022","author":"Premji","year":"2022","journal-title":"Case Rep. Hematol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1200\/JCO.19.02778","article-title":"Best Practices Guideline for the Pathologic Diagnosis of Breast Implant\u2013Associated Anaplastic Large-Cell Lymphoma","volume":"38","author":"Jaffe","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/cyt.12678","article-title":"A Practical Cytological Approach to the Diagnosis of Breast-Implant Associated Anaplastic Large Cell Lymphoma","volume":"30","year":"2019","journal-title":"Cytopathol. Off. J. Br. Soc. Clin. Cytol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/tbj.14205","article-title":"Next Generation Sequencing of Breast Implant-Associated Anaplastic Large Cell Lymphomas Reveals a Novel STAT3-JAK2 Fusion among Other Activating Genetic Alterations within the JAK-STAT Pathway","volume":"27","author":"Quesada","year":"2021","journal-title":"Breast J."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/cyto.b.22040","article-title":"Use of Flow Cytometry and Cytology to Differentiate Breast Implant-Associated Anaplastic Large Cell Lymphoma from Reactive Seromas in Brazilian Patients","volume":"102","author":"Gevert","year":"2022","journal-title":"Cytometry B Clin. Cytom."},{"key":"ref_236","first-page":"6478467","article-title":"Breast Implant\u2013Associated Anaplastic Large Cell Lymphoma: A Case Report and Review of the Literature","volume":"2017","author":"Ezekwudo","year":"2017","journal-title":"Case Rep. Oncol. Med."},{"key":"ref_237","first-page":"78","article-title":"Approach to Nodal-Based T-Cell Lymphomas","volume":"52","year":"2020","journal-title":"Pathology"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/tbj.13161","article-title":"Breast Implant-Associated Anaplastic Large Cell Lymphoma: Clinical and Imaging Findings at a Large US Cancer Center","volume":"25","author":"Dashevsky","year":"2019","journal-title":"Breast J."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/asj\/sjz243","article-title":"Comparative Analysis of Cytokines of Tumor Cell Lines, Malignant and Benign Effusions Around Breast Implants","volume":"40","author":"Kadin","year":"2020","journal-title":"Aesthet. Surg. J."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00262-020-02778-3","article-title":"IL-10, IL-13, Eotaxin and IL-10\/IL-6 Ratio Distinguish Breast Implant-Associated Anaplastic Large-Cell Lymphoma from All Types of Benign Late Seromas","volume":"70","author":"Greco","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"E312","DOI":"10.1002\/ajh.27055","article-title":"Diagnosis of Breast Implant Associated Anaplastic Large Cell Lymphoma by Analysis of Cytokines in Peri-implant Seromas","volume":"98","author":"Hu","year":"2023","journal-title":"Am. J. Hematol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/asj\/sjy250","article-title":"What Cytokines Can Tell Us About the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)","volume":"39","author":"Kadin","year":"2019","journal-title":"Aesthet. Surg. J."},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Alessandri-Bonetti, M., Jeong, T., Vaienti, L., De La Cruz, C., Gimbel, M.L., Nguyen, V.T., and Egro, F.M. (2023). The Role of Microorganisms in the Development of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Pathogens, 12.","DOI":"10.3390\/pathogens12020313"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/asj\/sjw023","article-title":"Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma","volume":"36","author":"Kadin","year":"2016","journal-title":"Aesthet. Surg. J."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3324\/haematol.2019.245860","article-title":"Molecular Profiling Reveals a Hypoxia Signature in Breast Implant-Associated Anaplastic Large Cell Lymphoma","volume":"106","author":"Oishi","year":"2021","journal-title":"Haematologica"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/CEJ.0000000000000809","article-title":"BIA-ALCL in Patients with Genetic Predisposition for Breast Cancer: Our Experience and a Review of the Literature","volume":"32","author":"Carbonaro","year":"2023","journal-title":"Eur. J. Cancer Prev. Off. J. Eur. Cancer Prev. Organ. ECP"},{"key":"ref_247","first-page":"360","article-title":"Gene Alterations in Epigenetic Modifiers and JAK-STAT Signaling Are Frequent in Breast Implant\u2013Associated ALCL","volume":"135","author":"Laurent","year":"2020","journal-title":"Blood"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"36126","DOI":"10.18632\/oncotarget.26308","article-title":"Frequent Activating STAT3 Mutations and Novel Recurrent Genomic Abnormalities Detected in Breast Implant-Associated Anaplastic Large Cell Lymphoma","volume":"9","author":"Blombery","year":"2018","journal-title":"Oncotarget"},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Harrop, S., Mehta-Shah, N., Dsouza, C., Thompson, E., Deva, A., and Prince, H.M. (2021). An Update on the Current Genomic Landscape of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Cancers, 13.","DOI":"10.3390\/cancers13194921"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2019-129123","article-title":"Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The Lymphoma Study Association (LYSA) Registry Data","volume":"134","author":"Gaulard","year":"2019","journal-title":"Blood"},{"key":"ref_251","doi-asserted-by":"crossref","unstructured":"Deva, A.K., Turner, S.D., Kadin, M.E., Magnusson, M.R., Prince, H.M., Miranda, R.N., Inghirami, G.G., and Adams, W.P. (2020). Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research. Cancers, 12.","DOI":"10.3390\/cancers12123861"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.humpath.2019.05.007","article-title":"Recurrent PDL1 Expression and PDL1 (CD274) Copy Number Alterations in Breast Implant-Associated Anaplastic Large-Cell Lymphomas","volume":"90","author":"Tabanelli","year":"2019","journal-title":"Hum. Pathol."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1182\/blood.2020005372","article-title":"Chromosome 20 Loss Is Characteristic of Breast Implant-Associated Anaplastic Large Cell Lymphoma","volume":"136","author":"Stathi","year":"2020","journal-title":"Blood"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/asj\/sjac234","article-title":"CD30 Regulation of IL-13-STAT6 Pathway in Breast Implant-Associated Anaplastic Large Cell Lymphoma","volume":"43","author":"Kadin","year":"2023","journal-title":"Aesthet. Surg. J."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2013.52.7911","article-title":"Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-up of 60 Patients","volume":"32","author":"Miranda","year":"2014","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Barrington","year":"2014","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/asj\/sjy331","article-title":"2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)","volume":"39","author":"Clemens","year":"2019","journal-title":"Aesthet. Surg. J."},{"key":"ref_259","first-page":"117","article-title":"Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Current Understanding and Recommendations for Management","volume":"28","author":"Pockaj","year":"2020","journal-title":"Plast. Surg. Oakv. Ont"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"169","DOI":"10.21037\/gs.2016.11.03","article-title":"Understanding Rare Adverse Sequelae of Breast Implants: Anaplastic Large-Cell Lymphoma, Late Seromas, and Double Capsules","volume":"6","author":"Clemens","year":"2017","journal-title":"Gland Surg."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.2015.63.3412","article-title":"Complete Surgical Excision Is Essential for the Management of Patients with Breast Implant-Associated Anaplastic Large-Cell Lymphoma","volume":"34","author":"Clemens","year":"2016","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_262","first-page":"47","article-title":"Treating Breast Implant-Associated Anaplastic Large Cell Lymphoma","volume":"34","author":"McKernan","year":"2021","journal-title":"JAAPA Off. J. Am. Acad. Physician Assist."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13000-023-01337-5","article-title":"Breast Implant Associated EBV-Positive Diffuse Large B-Cell Lymphoma: An Underrecognized Entity?","volume":"18","author":"Vets","year":"2023","journal-title":"Diagn. Pathol."},{"key":"ref_264","first-page":"2004","article-title":"EBV+ Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation Expands the Spectrum of Breast Implant-Related Lymphomas","volume":"135","author":"Mescam","year":"2020","journal-title":"Blood"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/SAP.0000000000002537","article-title":"Epstein-Barr Virus-Associated Diffuse Large B-Cell Lymphoma Identified in a Breast Implant Capsule: A New Breast Implant-Associated Lymphoma?","volume":"86","author":"Malata","year":"2021","journal-title":"Ann. Plast. Surg."},{"key":"ref_266","doi-asserted-by":"crossref","unstructured":"D\u2019Orsi, G., Giacalone, M., Calicchia, A., Gagliano, E., Vannucchi, L., Vanni, G., Buonomo, O.C., Cervelli, V., and Longo, B. (2024). BIA-ALCL and BIA-SCC: Updates on Clinical Features and Genetic Mutations for Latest Recommendations. Medicina, 60.","DOI":"10.3390\/medicina60050793"},{"key":"ref_267","unstructured":"Thursday, S. (2025, March 12). 8 ASPS Statement on Breast Implant Associated-Squamous Cell Carcinoma (BIA-SCC). Available online: https:\/\/www.plasticsurgery.org\/for-medical-professionals\/publications\/psn-extra\/news\/asps-statement-on-breast-implant-associated-squamous-cell-carcinoma."},{"key":"ref_268","doi-asserted-by":"crossref","unstructured":"Niraula, S., Katel, A., Barua, A., Weiss, A., Strawderman, M.S., Zhang, H., Manrique, O., O\u2019Connell, A., Pandey, S.R., and Dhakal, A. (2023). A Systematic Review of Breast Implant-Associated Squamous Cell Carcinoma. Cancers, 15.","DOI":"10.3390\/cancers15184516"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/j.semdp.2016.11.005","article-title":"A New Era for Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorders","volume":"34","author":"Kempf","year":"2017","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archdermatol.2009.280","article-title":"Applicability and Prognostic Value of the New TNM Classification System in 135 Patients with Primary Cutaneous Anaplastic Large Cell Lymphoma","volume":"145","author":"Benner","year":"2009","journal-title":"Arch. Dermatol."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/modpathol.2012.38","article-title":"Mucosal CD30-Positive T-Cell Lymphoproliferations of the Head and Neck Show a Clinicopathologic Spectrum Similar to Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorders","volume":"25","author":"Sciallis","year":"2012","journal-title":"Mod. Pathol."},{"key":"ref_272","first-page":"390","article-title":"Lymphomatoid Papulosis-Making Sense of the Alphabet Soup: A Proposal to Simplify Terminology","volume":"15","author":"Kempf","year":"2017","journal-title":"J. Dtsch. Dermatol. Ges. J. Ger. Soc. Dermatol. JDDG"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.humpath.2023.09.009","article-title":"Primary Cutaneous T-Cell Lymphoma: A Review of the Most Common Entities with Focus on Recent Updates","volume":"138","author":"Saleh","year":"2023","journal-title":"Hum. Pathol."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/PAS.0b013e318275d1a2","article-title":"TCR-\u03b3 Expression in Primary Cutaneous T-Cell Lymphomas","volume":"37","author":"Monsalvez","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/DAD.0000000000002014","article-title":"Primary Cutaneous Gamma-Delta T-Cell Lymphoma Mimicking Anaplastic Lymphoma Kinase-1-Negative Anaplastic Large Cell Lymphoma: A Case Report","volume":"44","author":"Meawad","year":"2022","journal-title":"Am. J. Dermatopathol."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/DAD.0000000000001630","article-title":"Does a Subset of Localized Chronic Fibrosing Vasculitis Represent Cutaneous Manifestation of IgG4-Related Disease\/a Histologic Pattern of IgG4-Related Skin Disease? A Reappraisal of an Enigmatic Pathologic Entity","volume":"42","author":"Tran","year":"2020","journal-title":"Am. J. Dermatopathol."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/ajcp\/aqab012","article-title":"How I Diagnose Anaplastic Large Cell Lymphoma","volume":"155","author":"Amador","year":"2021","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1365-2133.2010.09915.x","article-title":"Notch Signalling in Primary Cutaneous CD30+ Lymphoproliferative Disorders: A New Therapeutic Approach?","volume":"163","author":"Kamstrup","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2559.2009.03359.x","article-title":"Neutrophil\/Eosinophil-Rich Type of Primary Cutaneous Anaplastic Large Cell Lymphoma: A Clinicopathological, Immunophenotypic and Molecular Study of Nine Cases","volume":"55","author":"Kong","year":"2009","journal-title":"Histopathology"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0b013e3182648596","article-title":"Angioinvasive Lymphomatoid Papulosis: A New Variant Simulating Aggressive Lymphomas","volume":"37","author":"Kempf","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_281","doi-asserted-by":"crossref","unstructured":"Ortiz-Hidalgo, C., and Pina-Oviedo, S. (2023). Primary Cutaneous Anaplastic Large Cell Lymphoma\u2014A Review of Clinical, Morphological, Immunohistochemical, and Molecular Features. Cancers, 15.","DOI":"10.3390\/cancers15164098"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5826\/dpc.0501a06","article-title":"Hypopigmented Atypical Spitzoid Neoplasms (Atypical Spitz Nevi, Atypical Spitz Tumors, Spitzoid Melanoma): A Clinicopathological Update","volume":"5","author":"Ferrara","year":"2015","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/PAS.0000000000000217","article-title":"Intralymphatic Cutaneous Anaplastic Large Cell Lymphoma\/Lymphomatoid Papulosis: Expanding the Spectrum of CD30-Positive Lymphoproliferative Disorders","volume":"38","author":"Samols","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/DAD.0000000000001706","article-title":"Intravascular Cutaneous Disorders. A Clinicopathologic Review","volume":"43","author":"Cerroni","year":"2021","journal-title":"Am. J. Dermatopathol."},{"key":"ref_285","doi-asserted-by":"crossref","unstructured":"Zanelli, M., Parente, P., Sanguedolce, F., Zizzo, M., Palicelli, A., Bisagni, A., Carosi, I., Trombetta, D., Mastracci, L., and Ricci, L. (2022). Intravascular NK\/T-Cell Lymphoma: What We Know about This Diagnostically Challenging, Aggressive Disease. Cancers, 14.","DOI":"10.3390\/cancers14215458"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/modpathol.2010.225","article-title":"Specificity of IRF4 Translocations for Primary Cutaneous Anaplastic Large Cell Lymphoma: A Multicenter Study of 204 Skin Biopsies","volume":"24","author":"Wada","year":"2011","journal-title":"Mod. Pathol."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/pbc.26076","article-title":"Primary Cutaneous Lymphomas in Children and Adolescents","volume":"63","author":"Ceppi","year":"2016","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0560.2007.00778.x","article-title":"The Morphologic Spectrum of Primary Cutaneous Anaplastic Large T-Cell Lymphoma: A Histopathologic Study on 66 Biopsy Specimens from 47 Patients with Report of Rare Variants","volume":"35","author":"Massone","year":"2008","journal-title":"J. Cutan. Pathol."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1600-0560.2006.00560.x","article-title":"Detection of Clonal Rearrangement of T-Cell Receptor Genes in the Diagnosis of Primary Cutaneous CD30 Lymphoproliferative Disorders","volume":"33","author":"Greisser","year":"2006","journal-title":"J. Cutan. Pathol."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2014-07-588434","article-title":"A Novel Recurrent NPM1-TYK2 Gene Fusion in Cutaneous CD30-Positive Lymphoproliferative Disorders","volume":"124","author":"Velusamy","year":"2014","journal-title":"Blood"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/PAS.0000000000001449","article-title":"Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-Positive Primary Cutaneous Anaplastic Large Cell Lymphoma","volume":"44","author":"Melchers","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2016-02-694455","article-title":"No TP63 Rearrangements in a Selected Group of Primary Cutaneous CD30+ Lymphoproliferative Disorders with Aggressive Clinical Course","volume":"128","author":"Schrader","year":"2016","journal-title":"Blood"},{"key":"ref_293","doi-asserted-by":"crossref","unstructured":"Di Napoli, A., Vacca, D., Bertolazzi, G., Lopez, G., Piane, M., Germani, A., Rogges, E., Pepe, G., Santanelli Di Pompeo, F., and Salgarello, M. (2021). RNA Sequencing of Primary Cutaneous and Breast-Implant Associated Anaplastic Large Cell Lymphomas Reveals Infrequent Fusion Transcripts and Upregulation of PI3K\/AKT Signaling via Neurotrophin Pathway Genes. Cancers, 13.","DOI":"10.3390\/cancers13246174"},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/gcc.10184","article-title":"Genetic Alterations in Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma","volume":"37","author":"Mao","year":"2003","journal-title":"Genes. Chromosomes Cancer"},{"key":"ref_295","first-page":"100068","article-title":"Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders","volume":"2","author":"Abdulla","year":"2022","journal-title":"JID Innov. Skin Sci. Mol. Popul. Health"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/jid.2010.8","article-title":"Genome-Wide Analysis of Cutaneous T-Cell Lymphomas Identifies Three Clinically Relevant Classes","volume":"130","author":"Laharanne","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjd.13476","article-title":"Diagnostic and Prognostic Significance of CDKN2A\/CDKN2B Deletions in Patients with Transformed Mycosis Fungoides and Primary Cutaneous CD30-Positive Lymphoproliferative Disease","volume":"172","author":"Benner","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.humpath.2024.07.002","article-title":"DUSP22-Rearranged Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorders and Adult T-Cell Leukemia\/Lymphoma Frequently Share the LEF1+\/TIA1- Immunophenotype","volume":"150","author":"Chen","year":"2024","journal-title":"Hum. Pathol."},{"key":"ref_299","doi-asserted-by":"crossref","unstructured":"Gallardo, F., and Pujol, R.M. (2022). Genetics Abnormalities with Clinical Impact in Primary Cutaneous Lymphomas. Cancers, 14.","DOI":"10.3390\/cancers14204972"},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2162-3619-3-17","article-title":"Altered Expression Pattern of miR-29a, miR-29b and the Target Genes in Myeloid Leukemia","volume":"3","author":"Xu","year":"2014","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/jid.2014.487","article-title":"MicroRNA Expression Profiling and DNA Methylation Signature for Deregulated microRNA in Cutaneous T-Cell Lymphoma","volume":"135","author":"Sandoval","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1038\/jid.2015.328","article-title":"Notch1 Pathway Activation Results from the Epigenetic Abrogation of Notch-Related MicroRNAs in Mycosis Fungoides","volume":"135","author":"Gallardo","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_303","doi-asserted-by":"crossref","unstructured":"Hara, N., and Sawada, Y. (2022). Epigenetics of Cutaneous T-Cell Lymphomas. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073538"},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jid.2017.10.036","article-title":"Dual Role of EZH2 in Cutaneous Anaplastic Large Cell Lymphoma: Promoting Tumor Cell Survival and Regulating Tumor Microenvironment","volume":"138","author":"Yi","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3324\/haematol.2011.054619","article-title":"Histone Acetylation and DNA Demethylation of T Cells Result in an Anaplastic Large Cell Lymphoma-like Phenotype","volume":"98","author":"Joosten","year":"2013","journal-title":"Haematologica"},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1182\/blood-2011-05-351346","article-title":"EORTC, ISCL, and USCLC Consensus Recommendations for the Treatment of Primary Cutaneous CD30-Positive Lymphoproliferative Disorders: Lymphomatoid Papulosis and Primary Cutaneous Anaplastic Large-Cell Lymphoma","volume":"118","author":"Kempf","year":"2011","journal-title":"Blood"},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/bjd\/ljae150","article-title":"Paediatric-Onset Lymphomatoid Papulosis: Results of a Multicentre Retrospective Cohort Study on Behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG)","volume":"191","author":"Blanchard","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.clindermatol.2016.07.010","article-title":"Cutaneous Lymphoma: Kids Are Not Just Little People","volume":"34","author":"Ferenczi","year":"2016","journal-title":"Clin. Dermatol."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3892\/mco.2024.2733","article-title":"Challenges in Utilizing ALK Expression to Distinguish Primary Cutaneous from Systemic Anaplastic Large Cell Lymphoma","volume":"20","author":"Gleason","year":"2024","journal-title":"Mol. Clin. Oncol."},{"key":"ref_310","doi-asserted-by":"crossref","unstructured":"Swallow, M.A., Micevic, G., Zhou, A., Carlson, K.R., Foss, F.M., and Girardi, M. (2024). Clinical and Histologic Variants of CD8+ Cutaneous T-Cell Lymphomas. Cancers, 16.","DOI":"10.3390\/cancers16173087"},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jdv.16065","article-title":"Frequency and Prognosis of Associated Malignancies in 504 Patients with Lymphomatoid Papulosis","volume":"34","author":"Melchers","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jdv.15931","article-title":"Lymphomatoid Papulosis: An Update and Review","volume":"34","author":"Walsh","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jdcr.2019.01.009","article-title":"\u0393\u03b4 Lymphomatoid Papulosis Type D: A Histologic Mimic of Primary Cutaneous \u0393\u03b4 T-Cell Lymphoma","volume":"5","author":"Badje","year":"2019","journal-title":"JAAD Case Rep."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/PAP.0000000000000047","article-title":"Anaplastic Large Cell Lymphomas: ALK Positive, ALK Negative, and Primary Cutaneous","volume":"22","author":"Xing","year":"2015","journal-title":"Adv. Anat. Pathol."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/DAD.0b013e318289b1db","article-title":"Cutaneous Lymphomas: An Update. Part 1: T-Cell and Natural Killer\/t-Cell Lymphomas and Related Conditions","volume":"36","author":"Kempf","year":"2014","journal-title":"Am. J. Dermatopathol."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.jaad.2006.08.053","article-title":"Primary Cutaneous Anaplastic Large Cell Lymphoma with Fatal Leukemic Outcome in Association with CLA and CCR4-Negative Conversion","volume":"57","author":"Tokura","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/bjd.13690","article-title":"Assessment of Diagnostic Criteria between Primary Cutaneous Anaplastic Large-Cell Lymphoma and CD30-Rich Transformed Mycosis Fungoides; a Study of 66 Cases","volume":"172","author":"Fauconneau","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00428-021-03056-y","article-title":"Is Immunohistochemical Expression of GATA3 Helpful in the Differential Diagnosis of Transformed Mycosis Fungoides and Primary Cutaneous CD30-Positive T Cell Lymphoproliferative Disorders?","volume":"479","author":"Collins","year":"2021","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000431313","article-title":"Galectin-3 Expression in Primary Cutaneous CD30-Positive Lymphoproliferative Disorders and Transformed Mycosis Fungoides","volume":"231","author":"Mitteldorf","year":"2015","journal-title":"Dermatology"},{"key":"ref_320","doi-asserted-by":"crossref","unstructured":"Lai, P., Liu, F., Liu, X., Sun, J., and Wang, Y. (2023). Differential Molecular Programs of Cutaneous Anaplastic Large Cell Lymphoma and CD30-Positive Transformed Mycosis Fungoides. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1270365"},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/cup.14156","article-title":"Patch\/Plaque Mycosis-Fungoides-like Presentations of DUSP22-Translocated T-Cell Lymphomas","volume":"49","author":"Runge","year":"2022","journal-title":"J. Cutan. Pathol."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/his.14448","article-title":"DUSP22 Rearrangement in Primary Cutaneous T Cell Lymphoma with Features Intermediate between Mycosis Fungoides, Anaplastic Large-Cell Lymphoma and Lymphomatoid Papulosis","volume":"80","author":"Machan","year":"2022","journal-title":"Histopathology"},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/10428194.2023.2276678","article-title":"Primary Cutaneous Anaplastic Large Cell Lymphoma with DUSP22-Rearrangement Presenting as a Mimicker of Mycosis Fungoides: A Case Report and Review of the Literature","volume":"65","author":"Pacheco","year":"2024","journal-title":"Leuk. Lymphoma"},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/DAD.0000000000001423","article-title":"Mycosis Fungoides Associated With Lesions in the Spectrum of Primary Cutaneous CD30+ Lymphoproliferative Disorders: The Same Process or 3 Coexisting Lymphomas?","volume":"41","author":"Machan","year":"2019","journal-title":"Am. J. Dermatopathol."},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00428-022-03309-4","article-title":"Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+\u2009lymphoproliferation","volume":"481","author":"Bisig","year":"2022","journal-title":"Virchows. Arch."},{"key":"ref_326","doi-asserted-by":"crossref","unstructured":"Pileri, A., Cavicchi, M., Bertuzzi, C., Righi, S., Zengarini, C., Sabattini, E., Roncador, G., and Agostinelli, C. (2022). TOX Expression in Mycosis Fungoides and Sezary Syndrome. Diagnostics, 12.","DOI":"10.3390\/diagnostics12071582"},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/jid.2012.13","article-title":"Molecular Markers of Early-Stage Mycosis Fungoides","volume":"132","author":"Zhang","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"2","DOI":"10.12788\/j.sder.2018.002","article-title":"Mycosis Fungoides-Clinical and Histopathologic Features, Differential Diagnosis, and Treatment","volume":"37","author":"Cerroni","year":"2018","journal-title":"Semin. Cutan. Med. Surg."},{"key":"ref_329","unstructured":"(2024, October 08). Hematopathology of the Skin. Available online: https:\/\/shop.lww.com\/Hematopathology-of-the-Skin\/p\/9781975158552."},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/BLCTT.S142814","article-title":"Plasmablastic Lymphoma: Current Perspectives","volume":"8","author":"Lopez","year":"2018","journal-title":"Blood Lymphat. Cancer Targets Ther."},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/cup.12368","article-title":"Extracavitary Primary Effusion Lymphoma Presenting as a Cutaneous Tumor: A Case Report and Literature Review","volume":"41","author":"Pielasinski","year":"2014","journal-title":"J. Cutan. Pathol."},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2133.2003.05248.x","article-title":"Pyogenic Lymphoma of the Skin: A Peculiar Variant of Primary Cutaneous Neutrophil-Rich CD30+ Anaplastic Large-Cell Lymphoma. Clinicopathological Study of Four Cases and Review of the Literature","volume":"148","author":"Burg","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref_333","doi-asserted-by":"crossref","unstructured":"Chioureas, D., Beck, J., Baltatzis, G., Vardaki, I., Fonseca, P., Tsesmetzis, N., Vega, F., Leventaki, V., Eliopoulos, A.G., and Drakos, E. (2022). ALK+ Anaplastic Large Cell Lymphoma (ALCL)-Derived Exosomes Carry ALK Signaling Proteins and Interact with Tumor Microenvironment. Cancers, 14.","DOI":"10.3390\/cancers14122939"},{"key":"ref_334","first-page":"10","article-title":"Genetic Subtypes of Systemic Anaplastic Large Cell Lymphoma Show Distinct Differences in PD-L1 Expression and Regulatory and Cytotoxic T Cells in the Tumor Microenvironment","volume":"28","author":"Ferreira","year":"2020","journal-title":"Appl. Immunohistochem. Mol. Morphol. AIMM"},{"key":"ref_335","doi-asserted-by":"crossref","unstructured":"Lovisa, F., Di Battista, P., Gaffo, E., Damanti, C.C., Garbin, A., Gallingani, I., Carraro, E., Pillon, M., Biffi, A., and Bortoluzzi, S. (2020). RNY4 in Circulating Exosomes of Patients with Pediatric Anaplastic Large Cell Lymphoma: An Active Player?. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00238"},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"181","DOI":"10.59566\/IJBS.2011.7181","article-title":"Interleukin-2 Functions in Anaplastic Large Cell Lymphoma Cells through Augmentation of Extracellular Signal-Regulated Kinases 1\/2 Activation","volume":"7","author":"Ito","year":"2011","journal-title":"Int. J. Biomed. Sci. IJBS"},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.7150\/thno.45803","article-title":"pH-Responsive DNA Nanomicelles for Chemo-Gene Synergetic Therapy of Anaplastic Large Cell Lymphoma","volume":"10","author":"Li","year":"2020","journal-title":"Theranostics"},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3324\/haematol.2019.226647","article-title":"Defining Signatures of Peripheral T-Cell Lymphoma with a Targeted 20-Marker Gene Expression Profiling Assay","volume":"105","author":"Drieux","year":"2020","journal-title":"Haematologica"},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3324\/haematol.2022.281442","article-title":"ALK-Negative Anaplastic Large Cell Lymphoma with DUSP22 Rearrangement Has Distinctive Disease Characteristics with Better Progression-Free Survival: A LYSA Study","volume":"108","author":"Sibon","year":"2023","journal-title":"Haematologica"},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s41379-019-0448-9","article-title":"PD-L1 Expression in Anaplastic Large Cell Lymphoma","volume":"33","author":"Kong","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41379-019-0336-3","article-title":"PD-L1 Expression Is Associated with ALK Positivity and STAT3 Activation, but Not Outcome in Patients with Systemic Anaplastic Large Cell Lymphoma","volume":"33","author":"Shen","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/hon.2702","article-title":"High Intratumoural Galectin-1 Expression Predicts Adverse Outcome in ALK- ALCL and CD30+ PTCL-NOS","volume":"38","author":"Holst","year":"2020","journal-title":"Hematol. Oncol."},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"30e","DOI":"10.1097\/PRS.0000000000007423","article-title":"Cellular and Molecular Mechanisms of Breast Implant-Associated Anaplastic Large Cell Lymphoma","volume":"147","author":"DeCoster","year":"2021","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_344","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10549-016-3745-8","article-title":"MSCs and Inflammation: New Insights into the Potential Association between ALCL and Breast Implants","volume":"156","author":"Orciani","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1182\/blood-2002-02-0475","article-title":"Functional Expression of the Eotaxin Receptor CCR3 in CD30+ Cutaneous T-Cell Lymphoma","volume":"101","author":"Kleinhans","year":"2003","journal-title":"Blood"},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/cup.12719","article-title":"Characterization of the Tumor Microenvironment in Primary Cutaneous CD30-Positive Lymphoproliferative Disorders: A Predominance of CD163-Positive M2 Macrophages","volume":"43","author":"Tinguely","year":"2016","journal-title":"J. Cutan. Pathol."},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1007\/s12032-012-0244-6","article-title":"High Numbers of Tumor-Associated Macrophages Correlate with Poor Prognosis in Patients with Mature T- and Natural Killer Cell Lymphomas","volume":"29","author":"Lin","year":"2012","journal-title":"Med. Oncol."},{"key":"ref_348","doi-asserted-by":"crossref","unstructured":"Vaid, T., Gunning, T.S., Cohen, R., Della Pia, A., Voss, J., Weber, M., Pecora, A.L., Leslie, L.A., Feldman, T., and Goy, A.H. (2025). Next-Generation Sequencing Guides Diagnosis and Treatment in a Complex Presentation of ALK-Positive Anaplastic Large-Cell Lymphoma: A Case Report. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1502782"},{"key":"ref_349","doi-asserted-by":"crossref","unstructured":"Hsieh, W.-C., Budiarto, B.R., Wang, Y.-F., Lin, C.-Y., Gwo, M.-C., So, D.K., Tzeng, Y.-S., and Chen, S.-Y. (2022). Spatial Multi-Omics Analyses of the Tumor Immune Microenvironment. J. Biomed. Sci., 29.","DOI":"10.1186\/s12929-022-00879-y"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/12\/5871\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:54:48Z","timestamp":1760032488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/12\/5871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":349,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["ijms26125871"],"URL":"https:\/\/doi.org\/10.3390\/ijms26125871","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]}}}